Volume 35, 10 September 2004 9/2004
 
  SPOT ON
 

How do state authorities deal with illegal direct-to-consumer advertisement?

 
  NEW ON THE MARKET
 

Basal insulin analog detemir (LEVEMIR)

 
  BEWARE! MISSINFORMATION
 

Untrustworthy advertisement for chickenpox vaccine

 
  THERAPIES FROM A CRITICAL VIEW POINT

CARD-study: atorvastatin (SORTIS) in diabetes?
High-dose simvastatin (e.g. ZOCOR) in acute coronary syndrome?

 
  REVIEW
 

Perioperative management of oral anticoagulation

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Methyl-aminolevulinate (METVIX) in basal cell carcinoma
E.g. ct-generics: bribing prescribers

 
  IN BRIEF
 

Confirmed: compression stockings protect against post-thrombotic syndrome
Oseltamivir (TAMIFLU) - resistant mutants arise frequently
SSRI in pregnancy: withdrawal symptoms in the neonate

 
  CURRENT ADR NETWORK REPORT
 

Seizures with venlafaxine (TREVILOR)

 
  SIDE EFFECTS
 

Fatal liver failure associated with pioglitazone (ACTOS)
Nosebleed with antipsychotic risperidone (RISPERDAL)

 
© arznei-telegramm 9/2004